Loading…
Cyclosporine A–protection against microvascular hyperpermeability is calcineurin independent
Abstract Background Mitochondria-mediated apoptotic signaling contributes to microvascular hyperpermeability. We hypothesized that cyclosporine A (CsA), which protects mitochondrial transition pores, would attenuate hyperpermeability independent of its calcineurin inhibitory property. Methods Hyperp...
Saved in:
Published in: | The American journal of surgery 2010-04, Vol.199 (4), p.542-548 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c560t-dd8ea67807a8e3c569733b88ba28de3437ef1e471b6ca2257372674066ca53393 |
---|---|
cites | cdi_FETCH-LOGICAL-c560t-dd8ea67807a8e3c569733b88ba28de3437ef1e471b6ca2257372674066ca53393 |
container_end_page | 548 |
container_issue | 4 |
container_start_page | 542 |
container_title | The American journal of surgery |
container_volume | 199 |
creator | Childs, Ed W., M.D Tharakan, Binu, Ph.D Nurudeen, Suliat, B.S Delmas, Thomas L., B.S Hellman, Joseph, B.S Christie, Tasheika, B.S Hunter, Felicia A., B.S Smythe, W. Roy, M.D |
description | Abstract Background Mitochondria-mediated apoptotic signaling contributes to microvascular hyperpermeability. We hypothesized that cyclosporine A (CsA), which protects mitochondrial transition pores, would attenuate hyperpermeability independent of its calcineurin inhibitory property. Methods Hyperpermeability was induced in microvascular endothelial cell monolayers using proapoptotic BAK or active caspase-3 after CsA or a specific calcineurin inhibitor, calcineurin autoinhibitory peptide (CIP), treatment. Permeability was measured based on fluorescein isothiocyanate–albumin flux across the monolayers. Mitochondrial transmembrane potential (MTP) was determined using 5,5′,6,6′-tetrachoro-1,1′,3,3′-tetraethylbenzimidazolyl carbocyanine iodide. Mitochondrial release of cytochrome c was measured using an enzyme-linked immunosorbent assay and caspase-3 activity fluorometrically. Results CsA-attenuated (10 nmol/L) but not CIP-attenuated (100 μmol/L) BAK induced hyperpermeability ( P < .05), CsA- but not CIP-attenuated BAK induced a decrease in MTP and an increase in cytochrome c levels and caspase-3 activity ( P < .05). CsA and CIP were ineffective against caspase-3–induced hyperpermeability. Conclusions CsA attenuated hyperpermeability by protecting MTP, thus preventing mitochondria-mediated apoptotic signaling. The protective effect of CsA is independent of calcineurin inhibition. |
doi_str_mv | 10.1016/j.amjsurg.2009.11.002 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733846833</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002961009007600</els_id><sourcerecordid>1925902961</sourcerecordid><originalsourceid>FETCH-LOGICAL-c560t-dd8ea67807a8e3c569733b88ba28de3437ef1e471b6ca2257372674066ca53393</originalsourceid><addsrcrecordid>eNqFks9u1DAQxi0EotvCI4AicegpYWwnsXMBVSsKSJU4FK5YjjNbHPIPO6mUW9-BN-RJOqtdqNQLkmVrRp8_z_w8jL3ikHHg5ds2s30bl3CTCYAq4zwDEE_YhmtVpVxr-ZRtgFJpVXI4YacxthRynsvn7ESALKpC8Q37vl1dN8ZpDH7A5OLP3e8pjDO62Y9DYm-sH-Kc9N6F8dZGt3Q2JD_WCQOtHm3tOz-viY-Js50jh4VsEj80OCFtw_yCPdvZLuLL43nGvl1--Lr9lF59-fh5e3GVuqKEOW0ajbZUGpTVKClXKSlrrWsrdIMylwp3HHPF69JZIQollShVDiWFhZSVPGPnB1-q_teCcTa9jw67zg44LtGQnc5LLSUp3zxStuMSBirO8EoUFQgCRqrioKLGYwy4M1PwvQ2r4WD2_E1rjvzNnr_h3BBsuvf66L7UPTb_bv0FToL3BwESjVuPwUTncXDY-EDUTTP6_z7x7pGD6_zg6QN-4orxoRsThQFzvR-C_QxABaBKAHkPDwOv8A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1925902961</pqid></control><display><type>article</type><title>Cyclosporine A–protection against microvascular hyperpermeability is calcineurin independent</title><source>ScienceDirect Freedom Collection</source><creator>Childs, Ed W., M.D ; Tharakan, Binu, Ph.D ; Nurudeen, Suliat, B.S ; Delmas, Thomas L., B.S ; Hellman, Joseph, B.S ; Christie, Tasheika, B.S ; Hunter, Felicia A., B.S ; Smythe, W. Roy, M.D</creator><creatorcontrib>Childs, Ed W., M.D ; Tharakan, Binu, Ph.D ; Nurudeen, Suliat, B.S ; Delmas, Thomas L., B.S ; Hellman, Joseph, B.S ; Christie, Tasheika, B.S ; Hunter, Felicia A., B.S ; Smythe, W. Roy, M.D</creatorcontrib><description>Abstract Background Mitochondria-mediated apoptotic signaling contributes to microvascular hyperpermeability. We hypothesized that cyclosporine A (CsA), which protects mitochondrial transition pores, would attenuate hyperpermeability independent of its calcineurin inhibitory property. Methods Hyperpermeability was induced in microvascular endothelial cell monolayers using proapoptotic BAK or active caspase-3 after CsA or a specific calcineurin inhibitor, calcineurin autoinhibitory peptide (CIP), treatment. Permeability was measured based on fluorescein isothiocyanate–albumin flux across the monolayers. Mitochondrial transmembrane potential (MTP) was determined using 5,5′,6,6′-tetrachoro-1,1′,3,3′-tetraethylbenzimidazolyl carbocyanine iodide. Mitochondrial release of cytochrome c was measured using an enzyme-linked immunosorbent assay and caspase-3 activity fluorometrically. Results CsA-attenuated (10 nmol/L) but not CIP-attenuated (100 μmol/L) BAK induced hyperpermeability ( P < .05), CsA- but not CIP-attenuated BAK induced a decrease in MTP and an increase in cytochrome c levels and caspase-3 activity ( P < .05). CsA and CIP were ineffective against caspase-3–induced hyperpermeability. Conclusions CsA attenuated hyperpermeability by protecting MTP, thus preventing mitochondria-mediated apoptotic signaling. The protective effect of CsA is independent of calcineurin inhibition.</description><identifier>ISSN: 0002-9610</identifier><identifier>EISSN: 1879-1883</identifier><identifier>DOI: 10.1016/j.amjsurg.2009.11.002</identifier><identifier>PMID: 20359571</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Albumin ; Animals ; Apoptosis ; Apoptosis - drug effects ; Apoptosis Regulatory Proteins ; Attenuation ; BAK protein ; Calcineurin ; Calcineurin - metabolism ; Capillary Permeability - drug effects ; Carrier Proteins - metabolism ; Caspase ; Caspase Inhibitors ; Caspase-3 ; Cell death ; Cyclosporine - pharmacology ; Cyclosporins ; Cytochrome ; Cytochrome c ; Cytochromes c - metabolism ; Endothelium, Vascular - cytology ; Endothelium, Vascular - drug effects ; Enzyme-linked immunosorbent assay ; Fluorescein ; Fluorescein isothiocyanate ; Iodides ; Ischemia ; Kinases ; Laboratories ; Lung - blood supply ; Membrane potential ; Microcirculation ; Microvasculature ; Mitochondria ; Mitochondria - metabolism ; Monolayers ; Peptides ; Permeability ; Phenols ; Proteins ; Rats ; Rodents ; Signal Transduction - drug effects ; Studies ; Surgery ; Vascular permeability ; “Intrinsic” apoptotic cascade</subject><ispartof>The American journal of surgery, 2010-04, Vol.199 (4), p.542-548</ispartof><rights>Elsevier Inc.</rights><rights>2010 Elsevier Inc.</rights><rights>Copyright 2010 Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier Limited Apr 1, 2010</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c560t-dd8ea67807a8e3c569733b88ba28de3437ef1e471b6ca2257372674066ca53393</citedby><cites>FETCH-LOGICAL-c560t-dd8ea67807a8e3c569733b88ba28de3437ef1e471b6ca2257372674066ca53393</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20359571$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Childs, Ed W., M.D</creatorcontrib><creatorcontrib>Tharakan, Binu, Ph.D</creatorcontrib><creatorcontrib>Nurudeen, Suliat, B.S</creatorcontrib><creatorcontrib>Delmas, Thomas L., B.S</creatorcontrib><creatorcontrib>Hellman, Joseph, B.S</creatorcontrib><creatorcontrib>Christie, Tasheika, B.S</creatorcontrib><creatorcontrib>Hunter, Felicia A., B.S</creatorcontrib><creatorcontrib>Smythe, W. Roy, M.D</creatorcontrib><title>Cyclosporine A–protection against microvascular hyperpermeability is calcineurin independent</title><title>The American journal of surgery</title><addtitle>Am J Surg</addtitle><description>Abstract Background Mitochondria-mediated apoptotic signaling contributes to microvascular hyperpermeability. We hypothesized that cyclosporine A (CsA), which protects mitochondrial transition pores, would attenuate hyperpermeability independent of its calcineurin inhibitory property. Methods Hyperpermeability was induced in microvascular endothelial cell monolayers using proapoptotic BAK or active caspase-3 after CsA or a specific calcineurin inhibitor, calcineurin autoinhibitory peptide (CIP), treatment. Permeability was measured based on fluorescein isothiocyanate–albumin flux across the monolayers. Mitochondrial transmembrane potential (MTP) was determined using 5,5′,6,6′-tetrachoro-1,1′,3,3′-tetraethylbenzimidazolyl carbocyanine iodide. Mitochondrial release of cytochrome c was measured using an enzyme-linked immunosorbent assay and caspase-3 activity fluorometrically. Results CsA-attenuated (10 nmol/L) but not CIP-attenuated (100 μmol/L) BAK induced hyperpermeability ( P < .05), CsA- but not CIP-attenuated BAK induced a decrease in MTP and an increase in cytochrome c levels and caspase-3 activity ( P < .05). CsA and CIP were ineffective against caspase-3–induced hyperpermeability. Conclusions CsA attenuated hyperpermeability by protecting MTP, thus preventing mitochondria-mediated apoptotic signaling. The protective effect of CsA is independent of calcineurin inhibition.</description><subject>Albumin</subject><subject>Animals</subject><subject>Apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>Apoptosis Regulatory Proteins</subject><subject>Attenuation</subject><subject>BAK protein</subject><subject>Calcineurin</subject><subject>Calcineurin - metabolism</subject><subject>Capillary Permeability - drug effects</subject><subject>Carrier Proteins - metabolism</subject><subject>Caspase</subject><subject>Caspase Inhibitors</subject><subject>Caspase-3</subject><subject>Cell death</subject><subject>Cyclosporine - pharmacology</subject><subject>Cyclosporins</subject><subject>Cytochrome</subject><subject>Cytochrome c</subject><subject>Cytochromes c - metabolism</subject><subject>Endothelium, Vascular - cytology</subject><subject>Endothelium, Vascular - drug effects</subject><subject>Enzyme-linked immunosorbent assay</subject><subject>Fluorescein</subject><subject>Fluorescein isothiocyanate</subject><subject>Iodides</subject><subject>Ischemia</subject><subject>Kinases</subject><subject>Laboratories</subject><subject>Lung - blood supply</subject><subject>Membrane potential</subject><subject>Microcirculation</subject><subject>Microvasculature</subject><subject>Mitochondria</subject><subject>Mitochondria - metabolism</subject><subject>Monolayers</subject><subject>Peptides</subject><subject>Permeability</subject><subject>Phenols</subject><subject>Proteins</subject><subject>Rats</subject><subject>Rodents</subject><subject>Signal Transduction - drug effects</subject><subject>Studies</subject><subject>Surgery</subject><subject>Vascular permeability</subject><subject>“Intrinsic” apoptotic cascade</subject><issn>0002-9610</issn><issn>1879-1883</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNqFks9u1DAQxi0EotvCI4AicegpYWwnsXMBVSsKSJU4FK5YjjNbHPIPO6mUW9-BN-RJOqtdqNQLkmVrRp8_z_w8jL3ikHHg5ds2s30bl3CTCYAq4zwDEE_YhmtVpVxr-ZRtgFJpVXI4YacxthRynsvn7ESALKpC8Q37vl1dN8ZpDH7A5OLP3e8pjDO62Y9DYm-sH-Kc9N6F8dZGt3Q2JD_WCQOtHm3tOz-viY-Js50jh4VsEj80OCFtw_yCPdvZLuLL43nGvl1--Lr9lF59-fh5e3GVuqKEOW0ajbZUGpTVKClXKSlrrWsrdIMylwp3HHPF69JZIQollShVDiWFhZSVPGPnB1-q_teCcTa9jw67zg44LtGQnc5LLSUp3zxStuMSBirO8EoUFQgCRqrioKLGYwy4M1PwvQ2r4WD2_E1rjvzNnr_h3BBsuvf66L7UPTb_bv0FToL3BwESjVuPwUTncXDY-EDUTTP6_z7x7pGD6_zg6QN-4orxoRsThQFzvR-C_QxABaBKAHkPDwOv8A</recordid><startdate>20100401</startdate><enddate>20100401</enddate><creator>Childs, Ed W., M.D</creator><creator>Tharakan, Binu, Ph.D</creator><creator>Nurudeen, Suliat, B.S</creator><creator>Delmas, Thomas L., B.S</creator><creator>Hellman, Joseph, B.S</creator><creator>Christie, Tasheika, B.S</creator><creator>Hunter, Felicia A., B.S</creator><creator>Smythe, W. Roy, M.D</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20100401</creationdate><title>Cyclosporine A–protection against microvascular hyperpermeability is calcineurin independent</title><author>Childs, Ed W., M.D ; Tharakan, Binu, Ph.D ; Nurudeen, Suliat, B.S ; Delmas, Thomas L., B.S ; Hellman, Joseph, B.S ; Christie, Tasheika, B.S ; Hunter, Felicia A., B.S ; Smythe, W. Roy, M.D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c560t-dd8ea67807a8e3c569733b88ba28de3437ef1e471b6ca2257372674066ca53393</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Albumin</topic><topic>Animals</topic><topic>Apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>Apoptosis Regulatory Proteins</topic><topic>Attenuation</topic><topic>BAK protein</topic><topic>Calcineurin</topic><topic>Calcineurin - metabolism</topic><topic>Capillary Permeability - drug effects</topic><topic>Carrier Proteins - metabolism</topic><topic>Caspase</topic><topic>Caspase Inhibitors</topic><topic>Caspase-3</topic><topic>Cell death</topic><topic>Cyclosporine - pharmacology</topic><topic>Cyclosporins</topic><topic>Cytochrome</topic><topic>Cytochrome c</topic><topic>Cytochromes c - metabolism</topic><topic>Endothelium, Vascular - cytology</topic><topic>Endothelium, Vascular - drug effects</topic><topic>Enzyme-linked immunosorbent assay</topic><topic>Fluorescein</topic><topic>Fluorescein isothiocyanate</topic><topic>Iodides</topic><topic>Ischemia</topic><topic>Kinases</topic><topic>Laboratories</topic><topic>Lung - blood supply</topic><topic>Membrane potential</topic><topic>Microcirculation</topic><topic>Microvasculature</topic><topic>Mitochondria</topic><topic>Mitochondria - metabolism</topic><topic>Monolayers</topic><topic>Peptides</topic><topic>Permeability</topic><topic>Phenols</topic><topic>Proteins</topic><topic>Rats</topic><topic>Rodents</topic><topic>Signal Transduction - drug effects</topic><topic>Studies</topic><topic>Surgery</topic><topic>Vascular permeability</topic><topic>“Intrinsic” apoptotic cascade</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Childs, Ed W., M.D</creatorcontrib><creatorcontrib>Tharakan, Binu, Ph.D</creatorcontrib><creatorcontrib>Nurudeen, Suliat, B.S</creatorcontrib><creatorcontrib>Delmas, Thomas L., B.S</creatorcontrib><creatorcontrib>Hellman, Joseph, B.S</creatorcontrib><creatorcontrib>Christie, Tasheika, B.S</creatorcontrib><creatorcontrib>Hunter, Felicia A., B.S</creatorcontrib><creatorcontrib>Smythe, W. Roy, M.D</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Health & Medical Complete (ProQuest Database)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest_Research Library</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Childs, Ed W., M.D</au><au>Tharakan, Binu, Ph.D</au><au>Nurudeen, Suliat, B.S</au><au>Delmas, Thomas L., B.S</au><au>Hellman, Joseph, B.S</au><au>Christie, Tasheika, B.S</au><au>Hunter, Felicia A., B.S</au><au>Smythe, W. Roy, M.D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cyclosporine A–protection against microvascular hyperpermeability is calcineurin independent</atitle><jtitle>The American journal of surgery</jtitle><addtitle>Am J Surg</addtitle><date>2010-04-01</date><risdate>2010</risdate><volume>199</volume><issue>4</issue><spage>542</spage><epage>548</epage><pages>542-548</pages><issn>0002-9610</issn><eissn>1879-1883</eissn><abstract>Abstract Background Mitochondria-mediated apoptotic signaling contributes to microvascular hyperpermeability. We hypothesized that cyclosporine A (CsA), which protects mitochondrial transition pores, would attenuate hyperpermeability independent of its calcineurin inhibitory property. Methods Hyperpermeability was induced in microvascular endothelial cell monolayers using proapoptotic BAK or active caspase-3 after CsA or a specific calcineurin inhibitor, calcineurin autoinhibitory peptide (CIP), treatment. Permeability was measured based on fluorescein isothiocyanate–albumin flux across the monolayers. Mitochondrial transmembrane potential (MTP) was determined using 5,5′,6,6′-tetrachoro-1,1′,3,3′-tetraethylbenzimidazolyl carbocyanine iodide. Mitochondrial release of cytochrome c was measured using an enzyme-linked immunosorbent assay and caspase-3 activity fluorometrically. Results CsA-attenuated (10 nmol/L) but not CIP-attenuated (100 μmol/L) BAK induced hyperpermeability ( P < .05), CsA- but not CIP-attenuated BAK induced a decrease in MTP and an increase in cytochrome c levels and caspase-3 activity ( P < .05). CsA and CIP were ineffective against caspase-3–induced hyperpermeability. Conclusions CsA attenuated hyperpermeability by protecting MTP, thus preventing mitochondria-mediated apoptotic signaling. The protective effect of CsA is independent of calcineurin inhibition.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>20359571</pmid><doi>10.1016/j.amjsurg.2009.11.002</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-9610 |
ispartof | The American journal of surgery, 2010-04, Vol.199 (4), p.542-548 |
issn | 0002-9610 1879-1883 |
language | eng |
recordid | cdi_proquest_miscellaneous_733846833 |
source | ScienceDirect Freedom Collection |
subjects | Albumin Animals Apoptosis Apoptosis - drug effects Apoptosis Regulatory Proteins Attenuation BAK protein Calcineurin Calcineurin - metabolism Capillary Permeability - drug effects Carrier Proteins - metabolism Caspase Caspase Inhibitors Caspase-3 Cell death Cyclosporine - pharmacology Cyclosporins Cytochrome Cytochrome c Cytochromes c - metabolism Endothelium, Vascular - cytology Endothelium, Vascular - drug effects Enzyme-linked immunosorbent assay Fluorescein Fluorescein isothiocyanate Iodides Ischemia Kinases Laboratories Lung - blood supply Membrane potential Microcirculation Microvasculature Mitochondria Mitochondria - metabolism Monolayers Peptides Permeability Phenols Proteins Rats Rodents Signal Transduction - drug effects Studies Surgery Vascular permeability “Intrinsic” apoptotic cascade |
title | Cyclosporine A–protection against microvascular hyperpermeability is calcineurin independent |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T13%3A39%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cyclosporine%20A%E2%80%93protection%20against%20microvascular%20hyperpermeability%20is%20calcineurin%20independent&rft.jtitle=The%20American%20journal%20of%20surgery&rft.au=Childs,%20Ed%20W.,%20M.D&rft.date=2010-04-01&rft.volume=199&rft.issue=4&rft.spage=542&rft.epage=548&rft.pages=542-548&rft.issn=0002-9610&rft.eissn=1879-1883&rft_id=info:doi/10.1016/j.amjsurg.2009.11.002&rft_dat=%3Cproquest_cross%3E1925902961%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c560t-dd8ea67807a8e3c569733b88ba28de3437ef1e471b6ca2257372674066ca53393%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1925902961&rft_id=info:pmid/20359571&rfr_iscdi=true |